Literature DB >> 15300796

Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas.

Qunzhou Zhang1, Zuo-Feng Zhang, Jian Y Rao, J Denry Sato, Jimmy Brown, Diana V Messadi, Anh D Le.   

Abstract

Overexpression of hypoxia inducible factor-1alpha (HIF-1alpha) in cancers has been correlated to a more aggressive tumor phenotype. We investigated the effect of HIF-1alpha knockout on the in vitro survival and death of human tongue squamous cell carcinomas (SCC-4 and SCC-9). Under normoxic condition, a basal level of HIF-1alpha protein was constitutively expressed in SCC-9 cells, albeit an undetectable level of HIF-1alpha messages. Exposure to hypoxia induced only a transient increase in mRNA transcript but a prolonged elevation of HIF-1alpha protein and its immediate downstream target gene product, VEGF. Under normoxic or hypoxic conditions, treatment of SCC-9 cells with AS-HIF-1alpha ODN suppressed both constitutive and hypoxia-induced HIF-1alpha expression at both mRNA and protein levels. Knockout of HIF-1alpha gene expression via either AS-HIF-1alpha ODN or siRNA (siRNAHIF-1alpha) treatment resulted in inhibition of cell proliferation and induced apoptosis in SCC-4 and SCC-9 cells. We also demonstrated that exposure of SCC-9 cells to hypoxia led to a time-dependent increase in the expression of bcl-2 and IAP-2, but not p53. The attenuated levels of bcl-2 and IAP-2, and the enhanced activity of caspase-3 after treatment with AS-HIF-1alpha ODN may contribute partly to the effects of HIF-1alpha blockade on SCC-9 cell death. Collectively, our data suggest that a constitutive or hypoxia-induced expression of HIF-1alpha in SCC-9 and SCC-4 cells is sufficient to confer target genes expression essential for tumor proliferation and survival. As a result, interfering with HIF-1alpha pathways by antisense or siRNA strategy may provide a therapeutic target for human tongue squamous cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300796     DOI: 10.1002/ijc.20334

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Hypoxia preconditioning protects corneal stromal cells against induced apoptosis.

Authors:  Dongmei Xing; Xingcai Sun; Jinhua Li; Miao Cui; Kah Tan-Allen; Joseph A Bonanno
Journal:  Exp Eye Res       Date:  2005-12-20       Impact factor: 3.467

2.  Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.

Authors:  Xudong Tang; Qunzhou Zhang; Shihong Shi; Yun Yen; Xiangyong Li; Yuefei Zhang; Keyuan Zhou; Anh D Le
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

3.  HIF-1α regulated tongue squamous cell carcinoma cell growth via regulating VEGF expression in a xenograft model.

Authors:  Jun Liang; Zhaoqiang Zhang; Lizhong Liang; Yun Shen; Kexiong Ouyang
Journal:  Ann Transl Med       Date:  2014-09

4.  Anti-apoptotic action by hypoxia inducible factor 1-alpha in human pituitary adenoma cell line, HP-75 in hypoxic condition.

Authors:  Daizo Yoshida; Kyonsong Kim; Masahiro Noha; Akira Teramoto
Journal:  J Neurooncol       Date:  2006-06-16       Impact factor: 4.130

5.  Induction of hypoxia-inducible factor-1α by BDNF protects retinoblastoma cells against chemotherapy-induced apoptosis.

Authors:  Yu Gao; Ming Jing; Rongrong Ge; Lili Lang
Journal:  Mol Cell Biochem       Date:  2016-02-11       Impact factor: 3.396

6.  Role of Hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression.

Authors:  Li-Fang Fan; Wei-Guo Dong; Cong-Qing Jiang; Qun Qian; Qiong-Fang Yu
Journal:  Int J Colorectal Dis       Date:  2008-08-14       Impact factor: 2.571

Review 7.  Tumor microenvironment - Unknown niche with powerful therapeutic potential.

Authors:  Tomasz Kolenda; Weronika Przybyła; Marta Kapałczyńska; Anna Teresiak; Maria Zajączkowska; Renata Bliźniak; Katarzyna M Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-17

8.  BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.

Authors:  Ni Chen; Xueqin Chen; Rui Huang; Hao Zeng; Jing Gong; Wentong Meng; Yiping Lu; Fang Zhao; Lin Wang; Qiao Zhou
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

9.  Oxygen tension regulates preosteocyte maturation and mineralization.

Authors:  Adam M Zahm; Michael A Bucaro; Vickram Srinivas; Irving M Shapiro; Christopher S Adams
Journal:  Bone       Date:  2008-03-29       Impact factor: 4.398

10.  Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.

Authors:  Sreenivasulu Chintala; Károly Tóth; Shousong Cao; Farukh A Durrani; Mary M Vaughan; Randy L Jensen; Youcef M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  2010-01-12       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.